文献速递角膜与眼表疾病

原发性翼状胬肉辅助治疗比较:一项网络荟萃分析

Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
PubMed 文献 · Br J Ophthalmol · 2017-11-16

该网络荟萃分析检索1993至2015年 randomised clinical trials(RCTs),纳入24项RCT、1815眼、1668例患者,间接比较14种辅助干预预防原发性翼状胬肉术后复发。结论认为结膜自体移植联合环孢素0.05%滴眼液为最佳辅助治疗,单纯裸巩膜技术因高复发率应停止使用。

要点

  • 结膜自体移植联合环孢素0.05%滴眼液在14种辅助治疗中预防复发排名最佳。
  • 单纯裸巩膜技术因复发率高应停止使用。
  • 该网络荟萃分析纳入24项RCT、1815眼、1668例患者,比较14种干预。

核心结论

  • 预防原发性翼状胬肉术后复发的最佳辅助治疗是结膜自体移植联合环孢素0.05%滴眼液。
  • 单纯裸巩膜技术因复发率高应停止使用。

研究设计与样本

  • 网络荟萃分析,检索PubMed、Scientific Electronic Library Online、Latin American and Caribbean Centre on Health Sciences and Cochrane Eyes and Vision Group Trials Register于1993至2015年间发表的 randomised clinical trials(RCTs)。
  • 纳入24项RCT,共1815眼、1668例患者,通过直接和间接比较评估14种干预。

主要发现

  • 预防复发效果从最佳到最差的排序为:结膜自体移植联合环孢素0.05%滴眼液、裸巩膜联合术中丝裂霉素C(MMC)<0.02%、裸巩膜联合β射线治疗(单次剂量2500 cGy)、结膜自体移植联合β射线治疗(单次剂量1000 cGy)、裸巩膜联合MMC 0.02%滴眼液、结膜自体移植、裸巩膜联合术中MMC >0.02%、裸巩膜联合环孢素0.05%滴眼液、裸巩膜联合术中5-氟尿嘧啶5%、羊膜移植、裸巩膜联合术中MMC 0.02%、结膜自体移植联合贝伐珠单抗0.05%滴眼液、裸巩膜联合贝伐珠单抗0.05%滴眼液、单纯裸巩膜。

临床怎么用

  • 作者认为预防原发性翼状胬肉术后复发的最佳辅助治疗是结膜自体移植联合环孢素0.05%滴眼液。
  • 作者认为单纯裸巩膜技术因复发率高应停止使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pterygium is a frequent ocular disease, where the major challenge is the high level of recurrence after its surgical removal. We performed a network meta-analysis to identify, among several adjuvant treatments for primary pterygium, which is the best to prevent recurrence. METHODS: A search was conducted using PubMed, Scientific Electronic Library Online, Latin American and Caribbean Centre on Health Sciences and Cochrane Eyes and Vision Group Trials Register between 1993 and 2015 for randomisedclinical trials (RCTs) comparing adjuvant treatments following primary pterygium surgery. RESULTS: 24 RCTs that studied 1815 eyes of 1668 patients were included and allowed direct and indirect comparison among 14 interventions through network meta-analysis. The rank from the best to worse treatment to prevent recurrence is: conjunctival autograft + ciclosporin 0.05% eye drops, bare sclera + intraoperativemitomycin C (MMC) <0.02%, bare sclera + beta therapy (2500 cGy single dose), conjunctival autograft + beta therapy (1000 cGy single dose), bare sclera + MMC 0.02% eye drops, conjunctival autograft, bare sclera + intraoperative MMC >0.02%, bare sclera + ciclosporin 0.05% eye drops, bare sclera + intraoperative 5-fluorouracil 5%, amniotic membrane transplantation, bare sclera + intraoperative MMC 0.02%, conjunctival autograft + bevacizumab 0.05% eye drops, bare sclera + bevacizumab 0.05% eye drops and bare sclera alone. CONCLUSION: The best adjuvant treatment to prevent recurrence after primary pterygium surgery is the association of conjunctival autograft and ciclosporin 0.05% eye drops. Bare sclera technique alone should be discontinued since it is associated with high recurrence rates.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fonseca EC, Rocha EM, Arruda GV, et al. Comparison among adjuvant treatments for primary pterygium: a network meta-analysis. Br J Ophthalmol. 2017. PMID: 29146761. doi:10.1136/bjophthalmol-2017-310288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。